Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
10.70
-0.46 (-4.12%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of $295.51 million as of September 15, 2026. Its market cap has increased by 6.19% in one year.
Market Cap
295.51M
Enterprise Value
202.86M
1-Year Change
6.19%
Ranking
Category
Stock Price
$10.70
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from $10.33M to $295.51M, an increase of 2,760.51%. That is a compound annual growth rate of 36.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 295.51M | -14.62% |
| Dec 30, 2025 | 346.13M | 92.86% |
| Dec 30, 2024 | 179.47M | 14.25% |
| Dec 29, 2023 | 157.08M | 11.76% |
| Dec 30, 2022 | 140.55M | 27.27% |
| Dec 30, 2021 | 110.43M | -52.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 312.80M |
| Sionna Therapeutics | 311.06M |
| SAB Biotherapeutics | 310.26M |
| Vanda Pharmaceuticals | 301.71M |
| Clinuvel Pharmaceuticals | 300.65M |
| Upstream Bio | 300.15M |
| InflaRx | 297.68M |
| Zentalis Pharmaceuticals | 296.32M |